본문 바로가기
KERD
논문KCI 등재

The role of BCAA metabolism in metabolic health and disease

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

It has long been postulated that dietary restriction is beneficial for ensuring longevity and extending the health span of mammals, including humans. In particular, a reduction in protein consumption has been shown to be specifically linked to the beneficial effect of dietary restriction on metabolic disorders, presumably by reducing the activity of the mechanistic target of rapamycin complex (mTORC) 1 and the reciprocal activation of AMP-activated protein kinase (AMPK) and sirtuin pathways. Although it is widely used as a dietary supplement to delay the aging process in humans, recent evidence suggests that branched-chain amino acids (BCAAs) might be a major cause of the deteriorating effect of a protein diet on aging and related disorders. In this review, we delineate the regulation of metabolic pathways for BCAAs at the tissue-specific level and summarize recent findings regarding the role of BCAAs in the control of metabolic health and disease in mammals.

Abstract

It has long been postulated that dietary restriction is beneficial for ensuring longevity and extending the health span of mammals, including humans. In particular, a reduction in protein consumption has been shown to be specifically linked to the beneficial effect of dietary restriction on metabolic disorders, presumably by reducing the activity of the mechanistic target of rapamycin complex (mTORC) 1 and the reciprocal activation of AMP-activated protein kinase (AMPK) and sirtuin pathways. Although it is widely used as a dietary supplement to delay the aging process in humans, recent evidence suggests that branched-chain amino acids (BCAAs) might be a major cause of the deteriorating effect of a protein diet on aging and related disorders. In this review, we delineate the regulation of metabolic pathways for BCAAs at the tissue-specific level and summarize recent findings regarding the role of BCAAs in the control of metabolic health and disease in mammals.

참고문헌 (79)

  1. Lin, S. J., "Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration", Nature, 418, pp.344~348 (2002)
  2. Partridge, L., "Dietary restriction in Drosophila", Mech. Ageing Dev, 126, pp.938~950 (2005)
  3. Colman, R. J., "Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys", Nat. Commun, 5, pp.3557~ (2014)
  4. Saxton, R. A., "mTOR Signaling in growth, metabolism, and dis ease", Cell, 168, pp.960~976 (2017)
  5. Nakagawa, T., "Sirtuins at a glance", J. Cell Sci, 124, pp.833~838 (2011)
  6. Canto, C., "Calorie restriction: is AMPK a key sensor and effector?", Physiology, 26, pp.214~224 (2011)
  7. Solon-Biet, S. M., "Dietary protein to carbohydrate ratio and caloric restriction : comparing metabolic outcomes in mice", Cell Rep, 11, pp.1529~1534 (2015)
  8. Cummings, N. E., "Restoration of metabolic health by decreased consumption of branched-chain amino acids", J. Physiol, 596, pp.623~645 (2018)
  9. Solon-Biet, S. M., "Branched chain amino acids impact health and lifespan indirectly via amino acid balance and appetite control", Nat. Metab, 1, pp.532~545 (2019)
  10. Richardson, N. E., "Lifelong restriction of dietary branched-chain amino acids has sex-specific benefits for frailty and lifespan in mice", Nat. Aging, 1, pp.73~86 (2021)
  11. Lynch, C. J., "Branched-chain amino acids in metabolic signalling and insulin resistance", Nat. Rev. Endocrinol, 10, pp.723~736 (2014)
  12. Neinast, M., "Branched chain amino acids", Annu. Rev. Physiol, 81, pp.139~164 (2019)
  13. del Amo, E. M., "Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2", Eur. J. Pharm. Sci, 35, pp.161~174 (2008)
  14. Kanai, Y., "Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen(CD98)", J. Biol. Chem, 273, pp.23629~23632 (1998)
  15. Yanagida, O., "Human L-type amino acid transporter 1(LAT1) : characteriza tion of function and expression in tumor cell lines", Biochim Biophys. Acta, 1514, pp.291~302 (2001)
  16. Verrey, F., "CATs and HATs : the SLC7 family of amino acid transporters", Pflug. Arch, 447, pp.532~542 (2004)
  17. Ichihara, A., "Isozyme patterns of branched-chain amino acid transaminase during cellular differentiation and carcinogenesis", Ann. N. Y Acad. Sci, 259, pp.347~354 (1975)
  18. Kadowaki, H., "Cytosolic and mitochondrial isoenzymes of branched chain amino acid aminotransferase during development of the rat", Biochem. J, 202, pp.777~783 (1982)
  19. Patel, M. S., "The pyruvate dehydrogenase complexes: structure-based function and regulation", J. Biol. Chem, 289, pp.16615~16623 (2014)
  20. Paxton, R., "Isolation of rabbit liver branched chain alpha-ketoacid dehydrogenase and regulation by phosphorylation", J. Biol. Chem, 257, pp.14433~14439 (1982)
  21. Pettit, F. H., "Purification and characterization of bran ched chain alpha-keto acid dehydrogenase complex of bovine kidney", Proc. Natl. Acad. Sci. USA, 75, pp.4881~4885 (1978)
  22. Lu, G., "Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells", J. Clin. Investig, 119, pp.1678~1687 (2009)
  23. Biswas, D., "Role of branched-chain amino acid catabolizing enzymes in intertissue signaling, metabolic remodeling, and energy homeostasis", FASEB J, 33, pp.8711~8731 (2019)
  24. Fan, L., "Kruppel-like factor 15 : regulator of BCAA metabolism and circadian protein rhythmicity", Pharm. Res, 130, pp.123~126 (2018)
  25. McConnell, B. B., "Mammalian Kruppel-like factors in health and diseases", Physiol. Rev, 90, pp.1337~1381 (2010)
  26. Mori, T., "Role of Kruppel-like factor 15(KLF15)in transcriptional regulation of adipogenesis", J. Biol. Chem, 280, pp.12867~12875 (2005)
  27. Matoba, K., "Adipose KLF15 controls lipid handling to adapt to nutrient availability", Cell Rep, 21, pp.3129~3140 (2017)
  28. Prosdocimo, D. A., "Kruppel-like factor 15 is a critical regulator of cardiac lipid metabolism", J. Biol. Chem, 289, pp.5914~5924 (2014)
  29. Haldar, S. M., "Kruppel-like factor 15 regulates skeletal muscle lipid flux and exercise adaptation", Proc. Natl. Acad. Sci. USA, 109, pp.6739~6744 (2012)
  30. Sun, H., "Catabolic defect of branched-chain amino acids promotes heart failure", Circulation, 133, pp.2038~2049 (2016)
  31. Morrison-Nozik, A., "Glucocorticoids enhance muscle endurance and ame liorate Duchenne muscular dystrophy through a defined metabolic program", Proc. Natl. Acad. Sci. USA, 112, pp.E6780~E6789 (2015)
  32. Gray, S., "Regulation of gluconeogenesis by Kruppel-like factor 15", Cell Metab, 5, pp.305~312 (2007)
  33. Ahmadian, M., "PPARgamma signaling and metabolism : the good, the bad and the future", Nat. Med, 19, pp.557~566 (2013)
  34. Sears, D. D., "Mechanisms of human insulin resistance and thiazolidinedione mediated insulin sensitization", Proc. Natl. Acad. Sci. USA, 106, pp.18745~18750 (2009)
  35. Hsiao, G., "Multi-tissue, selective PPARgamma modulation of insulin sensi tivity and metabolic pathways in obese rats", Am. J. Physiol. Endocrinol. Metab, 300, pp.E164~E174 (2011)
  36. Blanchard, P. G., "PPARgamma is a major regulator of branched-chain amino acid blood levels and catabolism in white and brown adipose tissues", Metabolism, 89, pp.27~38 (2018)
  37. Neinast, M. D., "Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids", Cell Metab, 29, pp.417~429 (2019)
  38. Overmyer, K. A., "Maximal oxidative capacity during exercise is associated with skeletal muscle fuel selection and dynamic changes in mitochondrial pro tein acetylation", Cell Metab, 21, pp.468~478 (2015)
  39. Dohm, G. L., "Adaptation of protein metabolism to endurance training. Increased amino acid oxidation in response to training", Biochem. J, 164, pp.705~708 (1977)
  40. Herman, M. A., "Adipose tissue branched chain amino acid(BCAA)metabolism modulates circulating BCAA levels", J. Biol. Chem, 285, pp.11348~11356 (2010)
  41. Yoneshiro, T., "BCAA catabolism in brown fat controls energy homeostasis through SLC25A44", Nature, 572, pp.614~619 (2019)
  42. Wang, Q., "L-type amino acid transport and cancer : targeting the mTORC1 pathway to inhibit neoplasia", Am. J. Cancer Res, 5, pp.1281~1294 (2015)
  43. Yudkoff, M., "Brain metabolism of branched-chain amino acids", Glia, 21, pp.92~98 (1997)
  44. Sperringer, J. E., "Branched-chain amino acids and brain metabolism", Neurochem. Res, 42, pp.1697~1709 (2017)
  45. Gambello, M. J., "Current strategies for the treatment of inborn errors of metabolism", J. Genet. Genomics, 45, pp.61~70 (2018)
  46. Diaz, V. M., "Liver transplantation for classical maple syrup urine disease : long-term follow-up", J. Pediatr. Gastroenterol. Nutr, 59, pp.636~639 (2014)
  47. Sansbury, B. E., "Metabolomic analysis of pressure-overloaded and infarcted mouse hearts", Circ. Heart Fail, 7, pp.634~642 (2014)
  48. Ruiz-Canela, M., "Plasma branched-chain amino acids and incident cardio vascular disease in the PREDIMED Trial", Clin. Chem, 62, pp.582~592 (2016)
  49. Wang, W., "Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction", Am. J. Physiol. Heart Circ. y Physiol, 311, pp.H1160~H1169 (2016)
  50. Dodd, K. M., "Leucine and mTORC1 : a complex relationship", Am. J. Physiol. Endocrinol. Metab, 302, pp.E1329~E1342 (2012)
  51. McMullen, J. R., "Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload", Circulation, 109, pp.3050~3055 (2004)
  52. Burrage, L. C., "Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders", Mol. Genet. Metab, 113, pp.131~135 (2014)
  53. Felig, P., "Jr Plasma amino acid levels and insulin secretion in obesity", New Engl. J. Med, 281, pp.811~816 (1969)
  54. Chen, M., "Therapeutic effect of targeting branched-chain amino acid cata bolic flux in pressure-overload induced heart failure", J. Am. Heart Assoc, 8, pp.e011625~ (2019)
  55. Huffman, K. M., "Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women", Diabetes Care, 32, pp.1678~1683 (2009)
  56. Xu, F., "Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics", J. Clin. Endocrinol. Metab, 98, pp.E1060~E1065 (2013)
  57. She, P., "Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism", Am. J. Physiol. Endocrinol. Metab, 293, pp.E1552~E1563 (2007)
  58. Wang, T. J., "Metabolite profiles and the risk of developing diabetes", Nat. Med, 17, pp.448~453 (2011)
  59. McCormack, S. E., "Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents", Pediatr. Obes, 8, pp.52~61 (2013)
  60. Du, X., "Relationships between circulating branched chain amino acid con centrations and risk of adverse cardiovascular events in patients with STEMI treated with PCI", Sci. Rep, 8, pp.15809~ (2018)
  61. Le Couteur, D. G., "Branched chain amino acids, cardiometabolic risk factors and outcomes in older men : the concord health and ageing in men project", J. Gerontol. A Biol. Sci. Med. Sci, 75, pp.1805~1810 (2020)
  62. Portero, V., "Chronically elevated branched chain amino acid levels are pro arrhythmic", Cardiovasc Res, 118, pp.1742~1757 (2022)
  63. Laferrere, B., "Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss", Sci. Transl. Med, 3, pp.80re82~ (2011)
  64. Shah, S. H., "Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss", Diabetologia, 55, pp.321~330 (2012)
  65. Lackey, D. E., "Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity", Am. J. Physiol. Endocrinol. Metab, 304, pp.E1175~E1187 (2013)
  66. Jang, C., "A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance", Nat. Med, 22, pp.421~426 (2016)
  67. Vanweert, F., "A randomized placebo-controlled clinical trial for pharmaco logical activation of BCAA catabolism in patients with type 2 diabetes", Nat. Commun, 13, pp.3508~ (2022)
  68. Newgard, C. B., "A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance", Cell Metab, 9, pp.311~326 (2009)
  69. Xiao, F., "Effects of individual branched-chain amino acids deprivation on insulin sensitivity and glucose metabolism in mice", Metabolism, 63, pp.841~850 (2014)
  70. Yu, D., "The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine", Cell Metab, 33, pp.905~922 (2021)
  71. Fontana, L., "Decreased consumption of branched-chain amino acids improves metabolic health", Cell Rep, 16, pp.520~530 (2016)
  72. White, P. J., "Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export", Mol. Metab, 5, pp.538~551 (2016)
  73. McGarrah, R. W., "Dietary branched-chain amino acid restriction alters fuel selection and reduces triglyceride stores in hearts of Zucker fatty rats", Am. J. Physiol. Endocrinol. Metab, 318, pp.E216~E223 (2020)
  74. Ramzan, I., "A novel dietary intervention reduces circulatory branched-chain amino acids by 50%: a pilot study of relevance for obesity and diabetes", Nutrients (2020)[DOI]
  75. Karusheva, Y., "Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes : a randomized controlled crossover trial", Am. J. Clin. Nutr, 110, pp.1098~1107 (2019)
  76. Weaver, K. J., "Effects of hunger on neuronal histone modifications slow aging in Drosophila", Science, 380, pp.625~632 (2023)
  77. Liu, G. Y., "mTOR at the nexus of nutrition, growth, ageing and disease", Nat. Rev. Mol. Cell Biol, 21, pp.183~203 (2020)
  78. Han, H. S., "Impaired BCAA catabolism in adipose tissues promotes age associated metabolic derangement", Nat. Aging, 3, pp.982~1000 (2023)
  79. Green, C. L., "Dietary restriction of isoleucine increases healthspan and life span of genetically heterogeneous mice", Cell Metab, 35, pp.1976~1995 (2023)

관련 논문AI추천

이 간행물의 다른 논문 (218건)